| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) | 
|---|
| 03/10/2005 | US20050054536 Reacting an cyanoacrylate compound with amidine compound | 
| 03/10/2005 | US20050053678 Methods and compositions for betel nut chewing gum | 
| 03/09/2005 | EP1512397A1 O-substituted hydroxyaryl derivatives | 
| 03/09/2005 | EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor | 
| 03/09/2005 | CN1592618A Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same | 
| 03/09/2005 | CN1590384A Process for producing a pyran compound | 
| 03/09/2005 | CN1590372A Arylphenyl-substituted cyclic ketoenols | 
| 03/09/2005 | CN1192045C Synthesis of copolymers containing anhydrofructose derivatives | 
| 03/08/2005 | US6864397 E.g., 1-(4-(4-pentylcyclohexyl)cyclohexyldifluoromethoxy)-4 -trifluoromethoxybenzene; preparation from difluorocyclo-hexylidenes, e.g. 1-(4-(trans-4-propylcyclohexyl)cyclohexyl-difluoromethoxy)-3,4,5 -trifluorobenzene; liquid crystals | 
| 03/08/2005 | US6864278 Antifungal agents of sordarin derivatives | 
| 03/03/2005 | WO2005019159A1 OPTICALLY ACTIVE α-AMINOOXYKETONE DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | 
| 03/03/2005 | WO2004101508A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof | 
| 03/03/2005 | US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis | 
| 03/03/2005 | US20050049422 New salts of HMG-CoA reductase inhibitors | 
| 03/03/2005 | US20050049414 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof | 
| 03/03/2005 | US20050049283 Compounds that inhibit factor xa activity | 
| 03/03/2005 | US20050049280 e.g., ethyl 4-(hydroxyaminocarbonyl)-4-[4-(p-trifluoromethylphenoxy)piperidin-1-ylsulfonyl]piperidine-N-carboxylate | 
| 03/03/2005 | US20050049249 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors | 
| 03/03/2005 | US20050048315 Such as 4-(dicyanomethylene)-2-{p-(dialkylamino)styryl}-6-{p-(diarylamino)styryl}-4H-pyran; improved carrier transportation and exhibits long wavelength light | 
| 03/03/2005 | DE102004021338A1 New pyran compounds are useful as components in liquid crystalline media, preferably in optoelectronic displays | 
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors | 
| 03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators | 
| 02/24/2005 | WO2005016277A2 Arylsulfonamidobenzylic compounds | 
| 02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents | 
| 02/24/2005 | US20050043278 administering to a patient a hydroxy compound to treat aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, septicemia and syndrome X | 
| 02/24/2005 | CA2533638A1 Arylsulfonamidobenzylic compounds | 
| 02/23/2005 | EP1508560A2 Substituted Phenylketoenols | 
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function | 
| 02/23/2005 | CN1585767A Dimeric compounds and their use as anti-viral agents | 
| 02/23/2005 | CN1585766A Dimeric compounds and their use as anti-viral agents | 
| 02/23/2005 | CN1585765A Dimeric compounds and their use as anti-viral agents | 
| 02/23/2005 | CN1585764A Dimeric compounds and their use as anti-viral agents | 
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors | 
| 02/23/2005 | CN1583737A Synthesis of cinvastatin | 
| 02/23/2005 | CN1583736A Extraction and refinement of lovastatin | 
| 02/22/2005 | US6858749 Process for enantioselectively producing the (R)-delta-lactone | 
| 02/22/2005 | US6858741 Use as pesticides and herbicides | 
| 02/22/2005 | US6858724 Used as anti-tumor agents and/or anti-HIV agents having immunostimulate activities; inversion of OR2 to OR1 in glucopyranose derivtives (R1= H or acetyl, R2= a leaving group such as tosylate, trifluoromesylate or methanesulfonate | 
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors | 
| 02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors | 
| 02/17/2005 | WO2004067489A8 Hydroxyl compounds and compositions for cholesterol management and related uses | 
| 02/17/2005 | US20050038267 Pyran derivatives containing an exocyclic double bond | 
| 02/17/2005 | US20050038112 prevention, control and treatment of cancer; leukemia | 
| 02/17/2005 | US20050038108 4S, 5R, 6R)-5-Acetylamino-4-azido-6-[(S)-4-nitrophenoxycarbonyloxy)-(2-oxo-[1,3]dioxolan-4R-yl)methyl]- 5,6-dihydro-4H-pyran2-carboxylic acid methylester; modified at the carboxyl or hydroxyl or amino functions; orthomyxovirus and paramyxovirus infections; a long lung residency time and high potency | 
| 02/17/2005 | US20050038106 polyketides; for inhibiting proliferation of lung cancer or leukemia cells | 
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides | 
| 02/17/2005 | US20050037289 monomers that can be homopolymerized or copolymerized with other reactive components to make resins within sub-200 nanometer (nm) photoresist compositions | 
| 02/17/2005 | DE102004022891A1 Novel pyran compounds having exocyclic double bonds are useful as components in liquid crystalline media, preferably in optoelectronic displays | 
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors | 
| 02/16/2005 | EP1506211A1 C-aryl glucoside sglt2 inhibitors and method | 
| 02/16/2005 | EP1506183A1 Method of forming iron hydroxypyrone compounds | 
| 02/16/2005 | EP1506158A2 Diamino-functional chalcones | 
| 02/16/2005 | EP1506157A2 Amino-functional chalcones | 
| 02/16/2005 | EP1268463B1 Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade | 
| 02/16/2005 | EP1064285B1 Novel cephalotaxane derivatives and process for their preparation | 
| 02/16/2005 | EP0986540B1 The use of carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones as sodium channel blockers | 
| 02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity | 
| 02/14/2005 | WO2005024025A1 Polyene polyketides and methods of production | 
| 02/10/2005 | WO2005012279A1 Lactonization process | 
| 02/10/2005 | WO2005012246A1 Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin | 
| 02/10/2005 | WO2005012228A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity | 
| 02/10/2005 | WO2005012220A2 Cycloalkylidene compounds as modulators of estrogen receptor | 
| 02/10/2005 | US20050032883 Novel substance fki-1083 and process for producing the same | 
| 02/10/2005 | US20050032853 Intermediates for preparing neuraminidase inhibitor conjugates | 
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases | 
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases | 
| 02/10/2005 | US20050032176 Modular polyketide synthases with altered activity | 
| 02/09/2005 | EP1505050A1 Bridged carbocyclic compounds and methods of making and using same | 
| 02/09/2005 | EP1124443B1 Solid delivery systems for aroma ingredients | 
| 02/09/2005 | CN1578769A Processes for the manufacturing of 3-hydroxy-n, 1, 6-trialkyl-4-oxo-1, 4-dihydropyridine-2-carboxamide | 
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease | 
| 02/08/2005 | US6852711 HIV protease inhibitors | 
| 02/03/2005 | WO2005009983A1 Method for the detection of nucleophilic chemical species | 
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds | 
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds | 
| 02/02/2005 | EP1501844A1 Disaccharides for drug discovery | 
| 02/02/2005 | EP1501827A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acid and their use as protease inhibitors | 
| 02/02/2005 | EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators | 
| 02/02/2005 | EP1501800A1 Bombesin antagonists | 
| 02/02/2005 | EP1501791A1 Amino acid analogues | 
| 02/02/2005 | EP1501777A1 Direct, enantioselective aldol coupling of aldehydes using chiral organic catalysts | 
| 02/01/2005 | US6849744 3-(substituted phenyl),4-substituted-5H-1,2-oxathiole 2-oxide or 2,2-dioxide compounds useful as agricultural fungicides, insecticides, herbicides | 
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N | 
| 02/01/2005 | CA2276719C Anilide derivatives and antiarrhythmic agents containing the same | 
| 01/27/2005 | US20050020588 Cysteine protease inhibitors | 
| 01/27/2005 | US20050019278 Block solar radiation; applying to skin, hair | 
| 01/27/2005 | US20050017216 Liquid crystals; using metastasis catalysts; reduction, hydrogenation | 
| 01/26/2005 | EP1500643A1 Benzamide derivatives | 
| 01/26/2005 | EP1499573A1 Homogeneous process for the hydrogenation of carboxylic acids and derivatives thereof | 
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds | 
| 01/26/2005 | CN1186335C Process for obtaining HMG-CoA reductase inhibitors of high purity | 
| 01/20/2005 | WO2005005432A1 Novel 2,7-dioxo-bicyclo[4.3.0]non-5-yl-urea derivatives | 
| 01/20/2005 | WO2005005406A1 Process for production of 4-aminotetrahydropyrans and salts thereof with acids, intermediates for the process, and process for production thereof | 
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives | 
| 01/20/2005 | WO2004089926A8 Genipin derivatives and uses thereof | 
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient | 
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses | 
| 01/19/2005 | EP0777492B1 Combinatorial libraries of substrate-bound cyclic organic compounds | 
| 01/19/2005 | CN1568370A Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists | 
| 01/19/2005 | CN1185224C Oxidation of ketones to esters using tin substituted zeolite beta |